<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2012-12-17 13:41:39Anti-diabetic medication Leukotriene antagonist Non-steroidal anti-inflammatory drug Muscle relaxant Antibacterial Laxative Anticholinergic Antiestrogen Antiarrhythmic agent Medicine Analgesic Pain |
| Award ID: DP150096 Project Title: ESR1 Coregulator binding site inhibitors (ECBIs) as novel therapeutics to target hormone therapy resistant metastatic breast cancer Award Mechanism:DocID: 1aiKa - View Document |
| References for Substances Tested in the In Vitro ER Binding Assays: Appx D2 - ICCVAM ER Binding BRD (NIH Publication No[removed])DocID: RQPw - View Document |
| ACOG COMMITTEE OPINION Number 412 • August 2008 Aromatase Inhibitors in Gynecologic Practice Committee onDocID: PTgx - View Document |
| Shift work and adverse health effects: possible biological mechanismsDocID: G8Xf - View Document |
| Endocrine Disruptor Screening and Testing Advisory Committee Final Report - Appendix JDocID: A3xU - View Document |